Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK293S |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene EASY | publication | C.-Y. Lin et al., PLoS ONE, 2015, 10(4): e0123562; doi:10.1371/journal.pone.0123562 | Link | |||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | F. Walter, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 | ||||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | A.J. Jakobi et al., Nature Communications, 2020, 11: 440, doi.org/10.1038/s41467-020-14343-8 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | E. M. Lynes et al., J. Cell Sci., Sep 2013; 126: 3893 - 3903 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Pagano et al., 2014, US 8,778,905 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | S. Duvezin-Caubet et al., J. Biol. Chem., Dec 2006; 281: 37972 - 37979. | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | X. M. M. Weyel, Dissertation, 2018, Goethe- Universität in Frankfurt am Main | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | plasmid | Metafectene | publication | P. Aridon, Parkinsonism and Related Disorders, 2016, 31:135-138, doi.org/10.1016/j.parkreldis.2016.08.016 | ||||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | S. Kobe de Oliveira et al., J. Biol. Chem., May 2007; 282: 13656 - 13663 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | V. Mikat et al., RNA, Dec 2007; 13: 2341 - 2347 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | miRNA | Metafectene SI | publication | S. Smith, JCI Insight, 2018, 3(15):e120798, doi.org/10.1172/jci.insight.120798 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | K. Wethmar et al., Oncogene, 2016, 35,1736-1742; doi:10.1038/onc.2015.233 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | D. Kuchenov, Dissertation, 2019, University of Heidelberg | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. T. Hellwig et al., J. Biol. Chem., Aug 2008; 283: 21676 - 21685 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | L. Najmi, PhD Thesis, 2018, University of Bergen | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene EASY | publication | R. Hrdlickova et al., PLoS ONE, 2014, 9(2): e86990, doi:10.1371/journal.pone.0086990 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | miRNA | Metafectene PRO | publication | S. Demir, Master Thesis, 2012, Izmir Institute of Technology | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | Z. Knust et al., Infect. Immun., May 2009; 77: 1835 - 1841 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene EASY | publication | I. Park et al., Endocrinol. Metab., 2014, 29: 379-387, doi.org/10.3803/EnM.2014.29.3.379 | Link |